Table 6Evidence profile of comparisons of targeted immune modulators for the treatment of Crohn’s disease in adults

Number of studies/patientsDesignQualityConsistencyDirectnessMagnitude of effectOther modifying factorsOverall grade of the evidence
All comparisons
Outcome: Health outcomes
No evidence

From: Appendix I, Evidence profiles

Cover of Drug Class Review: Targeted Immune Modulators
Drug Class Review: Targeted Immune Modulators: Final Update 3 Report [Internet].
Thaler KJ, Gartlehner G, Kien C, et al.
Portland (OR): Oregon Health & Science University; 2012 Mar.
Copyright © 2012, Oregon Health & Science University, Portland, Oregon.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.